Vimarsana
Biggest News Aggregation in the World

Prospera Lung News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Prospera Lung. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Prospera Lung Today - Breaking & Trending Today

Natera Announces New Data From Two Studies Extending the Clinical Validation of Its Prospera™ Heart dd-cfDNA Test for Heart Transplant Recipients - Vimarsana News

Natera Announces New Data From Two Studies Extending the Clinical Validation of Its Prospera™ Heart dd-cfDNA Test for Heart Transplant Recipients

Prospective, multi-center Trifecta-Heart and DTRT-2 studies demonstrate excellent performance of the Prospera Heart test for detecting rejection in adults and pediatrics ...

Natera Receives Medicare Coverage for Prospera Lung Transplant Rejection Test - Vimarsana News

Natera Receives Medicare Coverage for Prospera Lung Transplant Rejection Test

The test will be covered under the existing LCD for molecular testing for solid organ transplant rejection in surveillance monitoring.

Natera's Prospera™ Lung Transplant Assessment Test Granted Medicare Coverage - Vimarsana News

Natera's Prospera™ Lung Transplant Assessment Test Granted Medicare Coverage

Represents third covered indication for Prospera ... -Today at 09:07 am- MarketScreener

Natera Publishes VALID Study Results for Prospera Lung dd-cfDNA Transplant Rejection Assessment Test - Vimarsana News

Natera Publishes VALID Study Results for Prospera Lung dd-cfDNA Transplant Rejection Assessment Test

/PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced the publication of the VALID study1, showcasing its...

Natera Expands Organ Health Business With Commercial Launch of the Prospera™ Lung Transplant Assessment Test - Vimarsana News

Natera Expands Organ Health Business With Commercial Launch of the Prospera™ Lung Transplant Assessment Test

/PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a leader in transforming care through genetic and cell-free DNA (cfDNA) testing, announced the launch and...